A 2016 study also showed that the SOCS1 mutations were exclusive to non-recurrent primary DLBCL and were completely absent in cases of relapsing DLBCL, which also supported a good prognosis (Juskevicius et al., 2016). The gene discussed is SOCS1; the disease is diffuse large B-cell lymphoma.